Detalhe da pesquisa
1.
Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
N Engl J Med
; 385(24): 2252-2263, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34449181
2.
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes.
N Engl J Med
; 383(23): 2219-2229, 2020 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33264825
3.
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis.
Eur Heart J
; 43(6): 474-484, 2022 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35023547
4.
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone.
Nephrol Dial Transplant
; 37(6): 1014-1023, 2022 05 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33280027
5.
Design and Baseline Characteristics of the Finerenone in Reducing Cardiovascular Mortality and Morbidity in Diabetic Kidney Disease Trial.
Am J Nephrol
; 50(5): 345-356, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665733
6.
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Am J Nephrol
; 50(5): 333-344, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31655812
7.
Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
Handb Exp Pharmacol
; 243: 271-305, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-27830348
8.
A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease.
Eur Heart J
; 37(27): 2105-14, 2016 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-27130705
9.
A Randomized Controlled Study of Finerenone vs. Eplerenone in Japanese Patients With Worsening Chronic Heart Failure and Diabetes and/or Chronic Kidney Disease.
Circ J
; 80(5): 1113-22, 2016 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-27074824
10.
Nonsteroidal antagonists of the mineralocorticoid receptor.
Curr Opin Nephrol Hypertens
; 24(5): 417-24, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26083526
11.
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.
JAMA
; 314(9): 884-94, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26325557
12.
Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy.
Am J Nephrol
; 40(6): 572-81, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25591469
13.
Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.
Eur Heart J
; 34(31): 2453-63, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23713082
14.
Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes.
J Hypertens
; 41(2): 295-302, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36583355
15.
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes.
Hypertension
; 79(12): 2685-2695, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36252131
16.
Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
JAMA
; 315(3): 306, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26784785
17.
Safety data and beneficial effects of the combined oral contraceptive ethinylestradiol 0.03 mg/chlormadinone acetate 2 mg (Belara®): a 13-cycle, observational study in routine clinical practice.
Clin Drug Investig
; 31(2): 121-34, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21155614
18.
A randomized controlled study of finerenone versus placebo in Japanese patients with type 2 diabetes mellitus and diabetic nephropathy.
J Diabetes Complications
; 31(4): 758-765, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025025
19.
Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.
Eur J Heart Fail
; 17(2): 224-32, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25678098
20.
Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document.
Eur J Heart Fail
; 15(10): 1082-94, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23787718